US Edition
Revive Therapeutics Announces Extension of Proposed Private Placement - Revive Therapeutics (OTC:RVVTF)
Revive Therapeutics plans to use the private placement funds for working capital and to pay trade debts, aiming to raise up to $650,000 by issuing over 30 million units.
Summary by Benzinga
10 Articles
10 Articles
Revive Therapeutics Announces Extension of Proposed Private Placement - Revive Therapeutics (OTC:RVVTF)
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF) (CSE:RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is extending is previously announced private placement offering of up to 30,952,381 units, at a price of $0.021 per unit, for gross proceeds to Revive of up to $650,000. Revive close…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources10
Leaning Left5Leaning Right2Center2Last UpdatedBias Distribution56% Left
Bias Distribution
- 56% of the sources lean Left
56% Left
L 56%
C 22%
R 22%
Factuality
To view factuality data please Upgrade to Premium
